370 related articles for article (PubMed ID: 38456597)
1. Cancer biology in diabetes update: Focusing on antidiabetic drugs.
Kawakita E; Kanasaki K
J Diabetes Investig; 2024 May; 15(5):525-540. PubMed ID: 38456597
[TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
3. Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.
Shlomai G; Neel B; LeRoith D; Gallagher EJ
J Clin Oncol; 2016 Dec; 34(35):4261-4269. PubMed ID: 27903154
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
Yurgin N; Secnik K; Lage MJ
Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
[TBL] [Abstract][Full Text] [Related]
5. New insights into antidiabetic drugs: Possible applications in cancer treatment.
Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Zarghami N
Chem Biol Drug Des; 2017 Dec; 90(6):1056-1066. PubMed ID: 28456998
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.
Pratley RE; Salsali A
Curr Med Res Opin; 2007 Apr; 23(4):919-31. PubMed ID: 17407649
[TBL] [Abstract][Full Text] [Related]
7. [Diabetes and cancer risk: oncologic considerations].
Rosta A
Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
[TBL] [Abstract][Full Text] [Related]
8. Noninsulin Diabetes Medications.
Varghese S
Nurs Clin North Am; 2017 Dec; 52(4):523-537. PubMed ID: 29080575
[TBL] [Abstract][Full Text] [Related]
9. Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications.
Huri HZ; Lim LP; Lim SK
Drug Des Devel Ther; 2015; 9():4355-71. PubMed ID: 26300627
[TBL] [Abstract][Full Text] [Related]
10. Effects of antidiabetic drugs on the incidence of macrovascular complications and mortality in type 2 diabetes mellitus: a new perspective on sodium-glucose co-transporter 2 inhibitors.
Rahelić D; Javor E; Lucijanić T; Skelin M
Ann Med; 2017 Feb; 49(1):51-62. PubMed ID: 27535028
[TBL] [Abstract][Full Text] [Related]
11. A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes.
Yaribeygi H; Atkin SL; Pirro M; Sahebkar A
J Cell Physiol; 2019 Jun; 234(6):8286-8294. PubMed ID: 30417367
[TBL] [Abstract][Full Text] [Related]
12. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
Vinik A
Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
[TBL] [Abstract][Full Text] [Related]
13. Diabesity and antidiabetic drugs.
Pappachan JM; Fernandez CJ; Chacko EC
Mol Aspects Med; 2019 Apr; 66():3-12. PubMed ID: 30391234
[TBL] [Abstract][Full Text] [Related]
14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
15. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
Vinik A
Clin Ther; 2007 Jun; 29(6 Pt 1):1236-53. PubMed ID: 18036387
[TBL] [Abstract][Full Text] [Related]
16. Antidiabetic medications in patients with type 2 diabetes mellitus and severe renal impairment: an update.
Aperis G
J Ren Care; 2012 Sep; 38(3):170-1. PubMed ID: 22883390
[No Abstract] [Full Text] [Related]
17. Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review.
Derosa G; Maffioli P
Clin Ther; 2012 Jun; 34(6):1221-36. PubMed ID: 22560622
[TBL] [Abstract][Full Text] [Related]
18. Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications.
Huri HZ; Ling DY; Ahmad WA
Drug Des Devel Ther; 2015; 9():4735-49. PubMed ID: 26316711
[TBL] [Abstract][Full Text] [Related]
19. Oral antidiabetic drug use and associated health outcomes in cancer patients.
Tan X; Feng X; Chang J; Higa G; Wang L; Leslie D
J Clin Pharm Ther; 2016 Oct; 41(5):524-31. PubMed ID: 27453485
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of factors associated with antidiabetic drug prescribing for type 2 diabetes mellitus.
Mahmoud F; Mullen A; Sainsbury C; Rushworth GF; Yasin H; Abutheraa N; Mueller T; Kurdi A
Eur J Clin Invest; 2023 Aug; 53(8):e13997. PubMed ID: 37002856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
